Molnupiravir Capsules 200 mg

Product Description

Molnupiravir Capsules 200mg  are a kind of experimental antiviral drugs that are developed by Merck and Ridgeback Biotherapeutics that is being examined for the treatment of COVID-19. It is an orally administered medicine, designed for inhibiting the replication of RNA viruses, comprising SARS-CoV-2, the virus that causes COVID-19. This type of antiviral drug works by introducing errors into the viral RNA throughout replication, which can lead to the particles of non-functional viral and a decrease in viral load. 200mg Molnupiravir Capsules are being studied as a potential treatment for people with mild to moderate COVID-19 who are at high risk of developing severe disease.